Ana Sahores Selected Research

Ana Sahores Research Topics

9	Neoplasms (Cancer) 01/2023 - 01/2010
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
3	Carcinoma (Carcinomatosis) 10/2018 - 06/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
1	Lymphatic Metastasis 01/2022
1	Adenocarcinoma 01/2019
1	Infections 10/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Hyperplasia 01/2010

7	Hormones (Hormone)IBA 01/2021 - 01/2010
4	Progestins (Progestagens)IBA 01/2022 - 01/2010
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2018 - 01/2010
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2010
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 01/2021
2	Phenobarbital (Luminal)FDA Link 01/2022 - 06/2012
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2018
2	Mifepristone (RU 486)FDA Link 01/2021 - 01/2010
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2016 - 06/2012
1	mRNA VaccinesIBA 01/2023
1	LigandsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Multidrug Resistance-Associated ProteinsIBA 01/2019
1	progesterone receptor AIBA 10/2018
1	infigratinibIBA 01/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	Estrogen ReceptorsIBA 06/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2012
1	Estrogens (Estrogen)FDA Link 06/2010
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2010